These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 32142018)
1. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords. Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018 [TBL] [Abstract][Full Text] [Related]
2. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy. Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432 [TBL] [Abstract][Full Text] [Related]
3. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375 [TBL] [Abstract][Full Text] [Related]
4. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection. Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS. de Castro A; Díaz A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M; Concheiro M Anal Bioanal Chem; 2013 May; 405(12):4295-305. PubMed ID: 23397092 [TBL] [Abstract][Full Text] [Related]
6. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy. González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834 [TBL] [Abstract][Full Text] [Related]
7. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry. Marin SJ; Metcalf A; Krasowski MD; Linert BS; Clark CJ; Strathmann FG; McMillin GA Ther Drug Monit; 2014 Feb; 36(1):119-24. PubMed ID: 24061447 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS. Feng J; Wang L; Dai I; Harmon T; Bernert JT J Anal Toxicol; 2007 Sep; 31(7):359-68. PubMed ID: 17725883 [TBL] [Abstract][Full Text] [Related]
9. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Colby JM Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850 [TBL] [Abstract][Full Text] [Related]
10. Detection of in utero cannabis exposure by umbilical cord analysis. Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698 [TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry. Ristimaa J; Gergov M; Pelander A; Halmesmäki E; Ojanperä I Anal Bioanal Chem; 2010 Sep; 398(2):925-35. PubMed ID: 20617307 [TBL] [Abstract][Full Text] [Related]
12. Universal Urine Drug Screening with Rapid Confirmation upon Admission to Labor and Delivery. Haizler-Cohen L; Collins A; Kaplan DM; Giri P; Davidov A; Blau J; Fruhman G Am J Perinatol; 2024 Aug; 41(11):1512-1520. PubMed ID: 37369238 [TBL] [Abstract][Full Text] [Related]
13. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center. Palmer KL; Wood KE; Krasowski MD Clin Biochem; 2017 Apr; 50(6):255-261. PubMed ID: 27890824 [TBL] [Abstract][Full Text] [Related]
14. Detection of opioids in umbilical cord lysates: an antibody-based rapid screening approach. Knight SJ; Smith AD; Wright TE; Collier AC Toxicol Mech Methods; 2019 Jan; 29(1):35-42. PubMed ID: 30064290 [TBL] [Abstract][Full Text] [Related]
15. Development of a liquid chromatography-tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure. Haglock-Adler CJ; McMillin GA; Strathmann FG Clin Biochem; 2016 Sep; 49(13-14):1092-5. PubMed ID: 27131494 [TBL] [Abstract][Full Text] [Related]
17. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population. Dale RC; Ford LT; Street C Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699 [TBL] [Abstract][Full Text] [Related]
18. Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. Marin SJ; Christensen RD; Baer VL; Clark CJ; McMillin GA Ther Drug Monit; 2011 Feb; 33(1):80-5. PubMed ID: 21192312 [TBL] [Abstract][Full Text] [Related]
19. Patterns of Neonatal Co-Exposure to Gabapentin and Commonly Abused Drugs Observed in Umbilical Cord Tissue. Okoye NC; McMillin GA J Anal Toxicol; 2021 May; 45(5):506-512. PubMed ID: 32860706 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Manchikanti L; Malla Y; Wargo BW; Fellows B Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]